Avidity will receive an upfront payment of
News
Keytruda combo wins FDA approval for RCC
The approval is based on results of the KEYNOTE-426 study, in which Keytruda in combination with Inlyta was found to reduce the risk of death by nearly half compared to Sutent.
PharmaTimes introduces a brand new category for the 2019 Communications Team of the Year competition
Due to the success of the Aspiring Communications Manager category which was introduced to the competition in 2018, this year has seen yet another entry point added for individuals, the Communications Manager of the Year.
First patient recruited in global AMD trial
The new treatment involves stimulating cells in the retina with light in a process called ‘photobiomodulation.’
NHS set to fund brain surgery for deaf children
The procedure involves inserting a device directly into the brain to stimulate hearing pathways.
Positive results for Eli Lilly’s Taltz in late stage non-radiographic axial spondyloarthritis trial
Taltz is also approved to treat adults with moderate-to-severe plaque psoriasis.
FDA permits marketing of first non-drug treatment for ADHD
The device generates a low-level electrical pulse and connects via a wire to a small patch that adheres to a patient’s forehead.
New breast cancer blood test could help spot relapse two years earlier
The blood test was able to detect 89% of all relapses, on average an impressive 8.9 months quicker than imaging.
‘Landmark’ study links air pollution to unborn baby growth
The study found evidence that exposure to nitrogen dioxide resulted in smaller fetal head size.
‘Fingerprint database’ could help pinpoint environmental cancer causes
Until now, scientists have had only a limited number of tools for working out the cause of an individual’s tumour.
NICE final guidance published for Cimzia
For adults who have failed to respond to, or are unsuitable for, other systemic therapies.
Public ‘unaware’ they have a choice of hospitals for NHS treatment
The legal right to choice has been in place for over a decade, but just 48% of the public are currently aware of it.
PureTech Health, Boehringer Ingelheim enter $26M immuno-oncology deal
PureTech Health will receive up to $26 million under the transaction.
Tickets available for the 20th International Clinical Researcher of the Year gala dinner & awards ceremony
Tickets are available for those wanting to be a part of one of the most important dates in the clinical research calendar – an evening of celebration and recognition for the very best clinical researchers from across the globe
New data reinforce effectiveness of Novartis’ Zolgensma for SMA
The Phase III STR1VE data showed that 21 patients were alive and event-free as of September 27 last year.
